Letters enclosing minutes of an Immuno meeting. Meeting Minutes details the difficulty Beecham had obtaining DHSS approval to change the vapour heat process for their products. The minutes explain that the vapour heat treatment developed by Immuno changes depending on the product so as not to affect the stability or the conditions needed to achieve virus inactivation. It mentions that DHSS is now regarded as one of the most stringent licensing authorities for blood products.